JP2013501770A - ウイルス感染症の治療 - Google Patents

ウイルス感染症の治療 Download PDF

Info

Publication number
JP2013501770A
JP2013501770A JP2012524290A JP2012524290A JP2013501770A JP 2013501770 A JP2013501770 A JP 2013501770A JP 2012524290 A JP2012524290 A JP 2012524290A JP 2012524290 A JP2012524290 A JP 2012524290A JP 2013501770 A JP2013501770 A JP 2013501770A
Authority
JP
Japan
Prior art keywords
compound
amino
chlorophenyl
propan
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012524290A
Other languages
English (en)
Japanese (ja)
Inventor
ジョン ブリュー、
ロビン マーク バニスター、
グレゴリー アラン ストロフ、
ウィルソン カッパロス ワンダレイ、
マテオ、 オルガ プレグェズェロス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocopea Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0913914A external-priority patent/GB0913914D0/en
Priority claimed from GBGB1001821.6A external-priority patent/GB201001821D0/en
Priority claimed from GB1012168A external-priority patent/GB2477584A/en
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of JP2013501770A publication Critical patent/JP2013501770A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2012524290A 2009-08-10 2010-08-10 ウイルス感染症の治療 Pending JP2013501770A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0913914A GB0913914D0 (en) 2009-08-10 2009-08-10 Treatment of viral infections
GB0913914.8 2009-08-10
GBGB1001821.6A GB201001821D0 (en) 2010-02-04 2010-02-04 Treatment of viral infections
GB1001821.6 2010-02-04
GB1012168A GB2477584A (en) 2010-02-04 2010-07-20 A compound for use in treating an acute viral infection
GB1012168.9 2010-07-20
PCT/GB2010/051317 WO2011018653A2 (en) 2009-08-10 2010-08-10 Treatment of viral infections

Publications (1)

Publication Number Publication Date
JP2013501770A true JP2013501770A (ja) 2013-01-17

Family

ID=43063293

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012524290A Pending JP2013501770A (ja) 2009-08-10 2010-08-10 ウイルス感染症の治療

Country Status (9)

Country Link
US (1) US20120283334A1 (https=)
EP (1) EP2464345A2 (https=)
JP (1) JP2013501770A (https=)
CN (1) CN102497860A (https=)
AU (1) AU2010283583A1 (https=)
IN (1) IN2012DN02123A (https=)
RU (1) RU2012108048A (https=)
SG (1) SG178345A1 (https=)
WO (1) WO2011018653A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108721262A (zh) * 2017-04-13 2018-11-02 中国科学院武汉病毒研究所 安非他酮在制备治疗或预防流感病毒感染的药物中的应用
CN115068453A (zh) * 2021-03-15 2022-09-20 中国医学科学院药物研究所 沙美特罗防治流感的药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4166955B2 (ja) * 1998-12-08 2008-10-15 プラニスフィア コーポレイション ウイルス疾患を処置するためのビュープロピオン
US20060173080A1 (en) * 2002-09-14 2006-08-03 The Regents Of The University Of California Methods of modulating TNF using bupropion
DE102004063132A1 (de) * 2004-12-22 2006-07-06 Schmiegel, Wolff, Prof. Dr. Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C

Also Published As

Publication number Publication date
IN2012DN02123A (https=) 2015-08-21
WO2011018653A2 (en) 2011-02-17
AU2010283583A1 (en) 2012-03-08
US20120283334A1 (en) 2012-11-08
WO2011018653A3 (en) 2011-04-07
EP2464345A2 (en) 2012-06-20
RU2012108048A (ru) 2013-09-20
SG178345A1 (en) 2012-03-29
CN102497860A (zh) 2012-06-13

Similar Documents

Publication Publication Date Title
KR102607599B1 (ko) 인플루엔자의 치료 방법
US11612574B2 (en) Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
JP2019203014A (ja) ウイルス感染症の治療用チアゾリド化合物
CN103648491B (zh) 用于抑制流感病毒复制的方法和药物组合物
US20180185404A1 (en) Compositions and methods for the treatment of viral infection
US11433080B2 (en) Antiviral treatment
US20240238269A1 (en) Use of 5-nitro-8-hydroxyquinoline
JP2013501770A (ja) ウイルス感染症の治療
US20130178466A1 (en) Treatment of Microbial Infections
JPWO2003035052A1 (ja) ウイルス感染予防・治療剤
GB2477584A (en) A compound for use in treating an acute viral infection
RU2842052C1 (ru) Азеластин в качестве противовирусного лечения
CN119235847B (zh) 一种化合物在制备抗流感病毒药物中的应用
US20210346459A1 (en) Application of Dalargin for the prevention of VRIs and prevention of the development of complications during VRIs
HK1069526B (en) Anti-influenza drugs